No black box warning on record for Oxbryta

As of the latest FDA labeling reviewed, Oxbryta (VOXELOTOR) does not carry a black box warning. Standard warnings and precautions still apply — see the full Oxbryta medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions: Observe for signs and symptoms and manage promptly. ( 5.1 ) • Laboratory Test Interference: Perform quantification of hemoglobin species when patient is not receiving OXBRYTA. ( 5.2 ) 5.1 Hypersensitivity Reactions Serious hypersensitivity reactions after administration of OXBRYTA have occurred in <1% of patients treated. Clinical manifestat

No black box warning on record for Oxbryta

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions: Observe for signs and symptoms and manage promptly. ( 5.1 ) • Laboratory Test Interference: Perform quantification of hemoglobin species when patient is not receiving OXBRYTA. ( 5.2 ) 5.1 Hypersensitivity Reactions Serious hypersensitivity reactions after administration of OXBRYTA have occurred in <1% of patients treated. Clinical manifestat

Oxbryta Black Box Warning

No black box warning on record for Oxbryta

Other warnings & precautions

Oxbryta Black Box Warning

No black box warning on record for Oxbryta

Other warnings & precautions